Evidence map›Paper›PMID 36060065›Full record

ArticleiScience2022

Convergent cerebrospinal fluid proteomes and metabolic ontologies in humans and animal models of Rett syndrome.

Stephanie A Zlatic, Duc Duong, Kamal K E Gadalla, Brenda Murage, Lingyan Ping, Ruth Shah, James J Fink, Omar Khwaja, Lindsay C Swanson, Mustafa Sahin and 8 more

Abstract read
In one paragraph

Article in iScience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Stephanie A ZlaticDepartments of Cell Biology, Emory University, Atlanta, GA 30322, USA.
Duc DuongDepartments of Biochemistry, Emory University, Atlanta, GA 30322, USA.
Kamal K E GadallaSimons Initiative for the Developing Brain, Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh EH8 9XD, UK.
Brenda MurageSimons Initiative for the Developing Brain, Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh EH8 9XD, UK.
Lingyan PingDepartments of Biochemistry, Emory University, Atlanta, GA 30322, USA.
Ruth ShahThe Wellcome Centre for Cell Biology, University of Edinburgh, Michael Swann Building, King's Buildings, Max Born Crescent, Edinburgh EH9 3BF, UK.
James J FinkQ-State Biosciences, Cambridge, MA 02139, USA.
Omar KhwajaDepartment of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Boston, MA 02115, USA.
Lindsay C SwansonDepartment of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Boston, MA 02115, USA.
Mustafa SahinDepartment of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Boston, MA 02115, USA.
Sruti RayaproluDepartments of Neurology, Emory University, Atlanta, GA 30322, USA.
Prateek KumarDepartments of Neurology, Emory University, Atlanta, GA 30322, USA.
Srikant RangarajuDepartments of Neurology, Emory University, Atlanta, GA 30322, USA.
Adrian BirdThe Wellcome Centre for Cell Biology, University of Edinburgh, Michael Swann Building, King's Buildings, Max Born Crescent, Edinburgh EH9 3BF, UK.
Daniel TarquinioCenter for Rare Neurological Diseases, Norcross, GA 30093, USA.
Randall CarpenterRett Syndrome Research Trust, Trumbull, CT 06611, USA.
Stuart CobbSimons Initiative for the Developing Brain, Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh EH8 9XD, UK.
Victor FaundezDepartments of Cell Biology, Emory University, Atlanta, GA 30322, USA.

Funding

Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Hisashi Umemori · 2021 to 2026
$9.4M
Targeting Kv1.3 potassium channels for neuro-immunomodulation in Alzheimer's DiseaseR01NS114130 · NINDS · YALE UNIVERSITY · PI RANGARAJU, SRIKANT · 2020 to 2024
$3.1M
Neuronal Mechanisms of Copper Transport and ToxicityRF1AG060285 · NIA · EMORY UNIVERSITY · PI FAUNDEZ, VICTOR · 2018 to 2021
$2.4M
Defining microglial and endothelial cell-type specific proteomic alterations of APOE risk in Alzheimer's diseaseF32AG064862 · NIA · EMORY UNIVERSITY · PI RAYAPROLU, SRUTI · 2019 to 2021
$195k
NIA NIH HHS F32 AG064862NIA NIH HHS RF1 AG060285NICHD NIH HHS P50 HD105351NINDS NIH HHS R01 NS114130
6 · The paper itself

Abstract

MECP2 loss-of-function mutations cause Rett syndrome, a neurodevelopmental disorder resulting from a disrupted brain transcriptome. How these transcriptional defects are decoded into a disease proteome remains unknown. We studied the proteome of Rett cerebrospinal fluid (CSF) to identify consensus Rett proteome and ontologies shared across three species. Rett CSF proteomes enriched proteins annotated to HDL lipoproteins, complement, mitochondria, citrate/pyruvate metabolism, synapse compartments, and the neurosecretory protein VGF. We used shared Rett ontologies to select analytes for orthogonal quantification and functional validation. VGF and ontologically selected CSF proteins had genotypic discriminatory capacity as determined by receiver operating characteristic analysis in

Indexed as

Clinical neuroscienceDiseasePathophysiologyProteomics

Identifiers

PMID36060065
PMCPMC9437849

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.